Showing results (301-310 of 369) with videos related to

Sort By:
Pageof 37
Blood|October 1, 1988
Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphomaA Ganser, C Carlo-Stella, C R Bartram, et al.
Annals of Hematology|March 23, 2004
Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trialG Heil, J Krauter, A Raghavachar, et al.
Annals of Hematology|April 1, 1996
Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherolA Ganser, A Maurer, C Contzen, et al.
International Archives of Allergy and Applied Immunology|January 1, 1990
Histamine release from basophils after in vivo application of recombinant human interleukin-3 in manR D Merget, A B Maurer, U Koch, et al.
British Journal of Cancer|June 10, 2004
Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapyE M Weissinger, K Oettrich, C Evans, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 19, 2011
Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantationS Borchers, S Luther, U Lips, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study GroupC Nickenig, M Dreyling, E Hoster, et al.
Oncogene|February 18, 1999
TIF1gamma, a novel member of the transcriptional intermediary factor 1 familyL Venturini, J You, M Stadler, et al.
Annals of Hematology|April 22, 1999
Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factorW K Hofmann, A Ganser, G Seipelt, et al.
Leukemia|February 20, 2003
The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AMLA Kaeferstein, U Krug, J Tiesmeier, et al.
Pageof 37